Bioline Rx Ltd - ADR

NASDAQ:BLRX   10:03:40 AM EDT
3.84
+0.08 (+2.08%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)16.36M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.67 Million
Adjusted EPS-$0.36
See more estimates
10-Day MA$3.83
50-Day MA$3.98
200-Day MA$4.52
See more pivots

Bioline Rx Ltd - ADR Stock, NASDAQ:BLRX

Modi'in Technology Park, 2 HaMa'ayan Street, Modi'in, HaMerkaz 7177871
Israel
Phone: +972.8.642.9100
Number of Employees: 38

Description

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.